Brain injury
Drug research and approvals for brain injury: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 839 studies of brain injury are recruiting on ClinicalTrials.gov, Health Canada has authorized 18 drug trials for it since 2013, and FDA has 0 approved and 5 open orphan designations naming it.
- Recruiting worldwide: 839
- Trials authorized in Canada: 18
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 839 recruiting on ClinicalTrials.gov ↗- Describing the Effect of Familiar Song on Arousal and Awareness for Children With Disorders of Consciousness (DoC)NCT07209657 · Not applicable · Murdoch Childrens Research Institute · starts Feb 1, 2027
- Effects of Moderate/Severe Traumatic Brain Injury in the Subacute or Chronic Phase on Locomotor Strategies Involved in…NCT07230002 · Not applicable · Pôle Saint Hélier · starts Jan 4, 2027
- Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)NCT07521930 · Not applicable · Johns Hopkins University · starts Jan 1, 2027
- Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord InjuryNCT07109804 · Not applicable · University of Miami · starts Dec 31, 2026
- Safety of Cultured Umbilical or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for CPNCT05018871 · Phase 1 · The Foundation for Orthopaedics and Regenerative Medicine · starts Dec 1, 2026
- Carbon Dioxide Administration and Brain Waste ClearanceNCT07357090 · Not applicable · Andrew Mayer · starts Nov 10, 2026
- Home-Based Exergame Motor-Cognitive Rehabilitation for Traumatic Brain InjuryNCT07733336 · Not applicable · Fondazione Don Carlo Gnocchi ETS · starts Nov 9, 2026
- Study on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With…NCT07844720 · Phase 2 · Institut National de la Santé Et de la Recherche Médicale, France · starts Nov 2, 2026
- An Early Feasibility Study of a Robotically Implanted Brain-Computer Interface for Neural Control of External Devices…NCT07929792 · Not applicable · Neuralink Corp · starts Nov 1, 2026
- Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryNCT07935278 · Phase 2 · HealthPartners Institute · starts Nov 1, 2026
Trials Authorized in Canada
The 10 newest of 18; search them all in Canada trials| Aug 15, 2025 | Brainapt – tbi international adaptative platform trialMETOPROLOL / PROPRANOLOL / PHENYTOIN / LEVETIRACETAM | CHU DE QUÉBEC-UNIVERSITÉ LAVAL | Ongoing |
| Aug 15, 2025 | A randomized, double-blind, placebo-controlled phase 2 exploratory study to evaluate the neuroprotective effects of av-001 on hemodialysis-induced brain injury…AV-001 | VASOMUNE THERAPEUTICS, INC. | Ongoing |
| Oct 10, 2024 | Psilocybin-assisted therapy for chronic traumatic brain injuryPSILOCYBIN | ROOTS TO THRIVE | Pending |
| Jul 26, 2024 | Frozen plasma in acute traumatic brain injury randomized controlled trial (f-tbi)FROZEN PLASMA | SUNNYBROOK RESEARCH INSTITUTE | Pending |
| Dec 20, 2023 | Beta blockers in traumatic brain injury (betrr)PROPRANOLOL | LONDON HEALTH SCIENCES CENTRE | Pending |
| Sep 26, 2023 | Effects of dexmedetomidine on agitation in critically ill tbi patients (dex-tbi)DEXMEDETOMIDINE | CIUSSS DU NORD-DE-L'ILE-DE-MONTRÉAL - HÔPITAL DU SACRÉ-COEUR DE MONTRÉAL. | Ongoing |
| Feb 2, 2023 | Treatment of neonatal encephalopathy with oral sildenafil suspension to repair brain injury secondary to birth asphyxia: a randomized, double-blind,…SILDENAFIL | RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE | Ongoing |
| Aug 11, 2022 | A phase I safety and feasibility study of metformin in infants after perinatal brain injuryMETFORMIN | THE HOSPITAL FOR SICK CHILDREN | Closed |
| May 22, 2019 | Prospective, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of nt 201 in the treatment of lower limb…XEOMIN (NT 201) | Merz Group | Closed |
| May 8, 2019 | Treatment of neonatal encephalopathy with oral sildenafil suspension to repair brain injury secondary to birth asphyxia: an open-label dose-finding clinical…SILDENAFIL | MONTREAL CHILDRENS HOSPITAL | Ongoing |
FDA Orphan Designations
Approved first, then open designations, newest first| Jul 24, 2012 | autologous umbilical cord bloodTreatment of pediatric (0-16 yrs old inclusive) cerebral palsy due to acquired brain injury | Duke University | Designated |
| Nov 23, 2010 | cyclosporine; ciclosporinTreatment of moderate to severe traumatic brain injury. | Owl Therapeutics | Designated |
| May 23, 2006 | Apomorphine hydrochlorideFor the treatment of patients in a vegetative state or minimally conscious state for up to 12 months following a severe traumatic brain… | NeuroHealing Pharmaceuticals, Inc. | Designated |
| Apr 15, 2005 | AnatibantTreatment of patients having experienced a severe traumatic brain injury (Glasgow Coma Scale 3 to 8) in order to decrease early mortality… | Xytis, Inc. | Designated |
| Aug 11, 2004 | dexanabinolFor the attenuation or amelioration of the long-term neurological sequelae associated with moderate and severe traumatic brain injury | Pharmos Corporation | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA